In the early stages of MS, mitochondrial ROS stimulate NLRP3 inflammasomes, and some antioxidants targeting mitochondria have shown anti‐inflammatory and neuroprotective activities in animal models of MS [116]. The gene discussed is NLRP3; the disease is myeloid sarcoma.